Two of the affected genes, MFSD2A and SLC39A1 have been reported as tumor suppressor genes in lung and prostate cancer, respectively, which by definition could carry mutations through the entire length [29–31]. This evidence concerns the gene SLC39A1 and Familial prostate cancer.